Sanofi UK is offering a 12-month alternance program focused on the patient journey for Type 1 diabetes, set to begin in September 2026. The role is designed for individuals looking to develop their skills while participating in the launch of a new treatment, with a strong emphasis on collaboration, creativity, and analytical thinking.
Not specified; Attractive remuneration mentioned; Includes profit sharing, employee stock plan, and social activities
Must-have
Nice-to-have
Apprenticeship contract required (learning or professionalization)